BAX
Baxter International Inc.
stockNYSE
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company's global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter's employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 24.92 | 2026-10-27 | +2.36% | 1.535 |
| 1M | 23.49 | 2026-10-02 | +8.59% | 0.722 |
| 3M | 28.10 | 2026-08-03 | -9.22% | 0.447 |
| 6M | 16.62 | 2026-05-04 | +53.48% | 0.602 |
| 1Y | 18.21 | 2025-11-03 | +40.08% | 1.043 |
| 2Y | 35.80 | 2024-11-04 | -28.75% | — |
| 5Y | 80.04 | 2021-11-03 | -68.13% | 0.700 |
Baxter International Inc. (NYSE:BAX) stock price today is $25.51, and today's volume is 6,979,537. BAX is up 5.317% today. The 30 day average volume is 7.06M. BAX market cap is $13.20B with 517.35M shares outstanding.